Literature DB >> 14316946

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

U R NILSSON, H J MUELLER-EBERHARD.   

Abstract

At least 3 complement factors were found necessary for the conversion of the thermolabile intermediate complex EAC'1a,4,2a to a thermostable state. One of these factors is the earlier described beta(1C)-globulin. The second, a heretofore unrecorded serum protein, beta(1F)-globulin. The third factor has not yet been defined as a discrete serum protein entity. Kinetic experiments indicated that beta(1C) reacted prior to beta(1F), which in turn seemed to precede the third factor in the reaction sequence. Therefore, the 3 components were tentatively designated the third (C'3), the fifth (C'5), and the sixth (C'6) components of complement, respectively. A procedure was developed allowing the isolation of highly purified beta(1C)-(C'3) and beta(1F)-globulin (C'5) and of partially purified C'6. With respect to its function in immune hemolysis, beta(1F)-globulin or C'5 was found to be closely dependent on the simultaneous presence of C'6. The hypothesis that C'5 and C'6 form a functional unit was supported by the finding that both components interact with each other in solution resulting in the formation of a complex. A similar complex was also found in fresh human serum.

Entities:  

Keywords:  BETA GLOBULIN; CHROMATOGRAPHY; COMPLEMENT; HEMOLYSIS; IMMUNOELECTROPHORESIS; IODINE ISOTOPES; KINETICS; ULTRACENTRIFUGATION

Mesh:

Substances:

Year:  1965        PMID: 14316946      PMCID: PMC2138056          DOI: 10.1084/jem.122.2.277

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  A SINGLE GENE CONTROLLING HEMOLYTIC COMPLEMENT AND A SERUM ANTIGEN IN THE MOUSE.

Authors:  R P ERICKSON; D K TACHIBANA; L A HERZENBERG; L T ROSENBERG
Journal:  J Immunol       Date:  1964-04       Impact factor: 5.422

2.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

3.  A gene locus concerned with hemolytic complement in Mus musculus.

Authors:  L A HERZENBERG; D K TACHIBANA; L A HERZENBERG; L T ROSENBERG
Journal:  Genetics       Date:  1963-05       Impact factor: 4.562

4.  A new supporting medium for preparative electrophoresis.

Authors:  H J MULLER-EBERHARD
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

5.  Starch gel electrophoresis in a discontinous system of buffers.

Authors:  M D POULIK
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

6.  Protein chromatography on calcium phosphate columns.

Authors:  S HJERTEN; O LEVIN; A TISELIUS
Journal:  Arch Biochem Biophys       Date:  1956-11       Impact factor: 4.013

7.  Complement and Hemolysis.

Authors:  H J Rapp; T Borsos
Journal:  Science       Date:  1963-08-23       Impact factor: 47.728

8.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

9.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Isolation and characterization of two beta1-glycoproteins of human serum.

Authors:  H J MULLER-EBERHARD; U NILSSON; T ARONSSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  179 in total

1.  Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

Authors:  S Ruddy; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  A unique complement derived chemotactic factor for tumor cells.

Authors:  A G Romualdez; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

4.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

6.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

7.  Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

8.  Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.

Authors:  M R Smith; H S Shin; W B Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

9.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

10.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.